Dr. Rinki G. Agarwal, MD

Dr. Agarwal practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Agarwal's NPI, 1205074085, was assigned on February 1, 2009. Dr. Agarwal graduated from Padmashree Dr. D.Y. Patil Medical College in 2001. Dr. Agarwal holds New York license 246168.

Dr. Agarwal's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Agarwal's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Agarwal is also affiliated with Crouse Hospital. The medical group on file is University OB/GYN Associates. Dmand AI also links Dr. Agarwal to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Agarwal is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Agarwal's licenses on file in 2 states: New York and California.

Dmand AI lists hysterectomy, menopause and vaginal infection among the conditions Dr. Agarwal treats.

CMS data shows 137 Medicare services from Dr. Agarwal across 4 procedure codes in 2024, all of them office visits, for 88 Medicare patients. Medicare paid $10,652 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 88 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 37 patients. 74% of them have high blood pressure, and 67% have cancer. 17% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 62, with 96% women.

In 2024, Dr. Agarwal wrote 140 Medicare Part D claims for 68 patients. 89% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $657 in total drug cost. In 2023, CMS named 90 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Agarwal for performance year 2024, reported as part of a group. Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agarwal as offering telehealth. CMS counts 12 procedures of removal of the uterus by Dr. Agarwal, more than 86% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 36 general payments to Dr. Agarwal from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Pfizer Inc. paid the most, $1,433.

Dr. Agarwal graduated from Padmashree Dr. D.Y. Patil Medical College in 2001.

Dr. Agarwal is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.